BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10853810)

  • 1. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
    Weber WA; Wester HJ; Grosu AL; Herz M; Dzewas B; Feldmann HJ; Molls M; Stöcklin G; Schwaiger M
    Eur J Nucl Med; 2000 May; 27(5):542-9. PubMed ID: 10853810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-Related Uptake of
    Geisler S; Stegmayr C; Niemitz N; Lohmann P; Rapp M; Stoffels G; Willuweit A; Galldiks N; Filss C; Sabel MC; Coenen HH; Shah NJ; Langen KJ
    J Nucl Med; 2019 Oct; 60(10):1373-1379. PubMed ID: 30850492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.
    Weckesser M; Langen KJ; Rickert CH; Kloska S; Straeter R; Hamacher K; Kurlemann G; Wassmann H; Coenen HH; Schober O
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):422-9. PubMed ID: 15650870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.
    Salber D; Stoffels G; Pauleit D; Oros-Peusquens AM; Shah NJ; Klauth P; Hamacher K; Coenen HH; Langen KJ
    J Nucl Med; 2007 Dec; 48(12):2056-62. PubMed ID: 18006612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
    Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
    Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
    J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
    Makrides V; Bauer R; Weber W; Wester HJ; Fischer S; Hinz R; Huggel K; Opfermann T; Herzau M; Ganapathy V; Verrey F; Brust P
    Brain Res; 2007 May; 1147():25-33. PubMed ID: 17343835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia.
    Salber D; Stoffels G; Pauleit D; Reifenberger G; Sabel M; Shah NJ; Hamacher K; Coenen HH; Langen KJ
    Nucl Med Biol; 2006 Nov; 33(8):1029-35. PubMed ID: 17127177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.
    Stegmayr C; Willuweit A; Lohmann P; Langen KJ
    Curr Radiopharm; 2019; 12(3):201-210. PubMed ID: 30636621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.
    Stöber B; Tanase U; Herz M; Seidl C; Schwaiger M; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):932-9. PubMed ID: 16604346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
    Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
    J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
    Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
    J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
    J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
    Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
    Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
    Pöpperl G; Götz C; Rachinger W; Gildehaus FJ; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1464-70. PubMed ID: 15248032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
    Pöpperl G; Goldbrunner R; Gildehaus FJ; Kreth FW; Tanner P; Holtmannspötter M; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1018-25. PubMed ID: 15877226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
    Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
    J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of factors influencing
    Verger A; Stegmayr C; Galldiks N; Van Der Gucht A; Lohmann P; Stoffels G; Shah NJ; Fink GR; Eickhoff SB; Guedj E; Langen KJ
    Neuroimage Clin; 2018; 17():491-497. PubMed ID: 29159062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.